# Cambrex Profarmaco Milano Srl – FDA Inspection, Nov 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/d517f310-c80c-4a43-a918-722116697891
Source feed: FDA_Inspections

> FDA inspection 1193220 of Cambrex Profarmaco Milano Srl, November 11, 2022. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1193220
- Company Name: Cambrex Profarmaco Milano Srl
- Inspection Date: 2022-11-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1167505 - 2021-10-01
- FDA Inspection 1091698 - 2019-05-07
- [FDA Inspection 1021644 - 2017-05-19](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/66ac1960-e277-4a92-bdb1-667be3edb250)
- FDA Inspection 973972 - 2015-11-06
- FDA Inspection 861141 - 2013-12-06

Company: https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c